13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 124 holding rows worth $5,509,809,264.
- Accession
- 0001213900-25-076586
- Filer
- CIK 1009258
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 124 entries on the cover page, a total value of $5,509,809,264 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,509,809,264 with VALUE read as dollars as filed, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVALENT INC COM | 670703107 | Stock | 17,991,024 | $1,372,715,131 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 11,649,591 | $249,767,231 | dollars as filed | |
| VIATRIS INC COM | 92556V106 | Stock | 24,023,907 | $214,533,490 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 3,384,628 | $178,031,433 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 3,185,370 | $172,901,884 | dollars as filed | |
| INTEGRA LIFESCIENCES HLDGS C | 457985AM1 | NOTE 0.500% 8/1 | 174,364,000 | $172,859,587 | dollars as filed | principal |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 9,724,508 | $169,692,665 | dollars as filed | |
| Indivior PLC | G4766E116 | Common Stock | 10,567,160 | $155,759,938 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 540,626 | $155,348,881 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,167,802 | $146,781,033 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC | 02043QAB3 | NOTE 1.000% 9/1 | 110,000,000 | $143,172,150 | dollars as filed | principal |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,384,072 | $124,500,009 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749AB7 | NOTE 4.000% 5/0 | 70,000,000 | $124,213,180 | dollars as filed | principal |
| BROOKDALE SR LIVING INC | 112463104 | COM | 15,362,264 | $106,921,357 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 2,962,338 | $105,133,376 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 4,306,264 | $104,383,839 | dollars as filed | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 9,904,895 | $93,403,160 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 5,115,953 | $92,649,909 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,915,311 | $82,299,837 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 3,348,117 | $78,881,637 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 700,700 | $70,518,448 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 857,724 | $67,897,432 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 2,879,476 | $62,484,629 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 21,231,974 | $61,360,405 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 1,923,100 | $58,231,468 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 226,070 | $54,555,212 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 919,403 | $48,691,583 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 145,000 | $47,283,050 | dollars as filed | |
| ENHABIT INC | 29332G102 | COM | 4,779,864 | $46,077,889 | dollars as filed | |
| CERTARA INC COM | 15687V109 | Stock | 3,926,099 | $45,935,358 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 2,215,845 | $43,297,611 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 4,692,000 | $42,040,320 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372AD6 | NOTE 1.500% 3/1 | 40,000,000 | $38,516,440 | dollars as filed | principal |
| CONMED CORP COM | 207410101 | Stock | 700,271 | $36,470,114 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 2,017,464 | $35,507,366 | dollars as filed | |
| Lantheus Hldgs Inc Note 2.625 percent 12/1 | 516544AB9 | Convertible | 25,255,000 | $32,062,687 | dollars as filed | principal |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 3,855,552 | $29,032,307 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 686,931 | $28,885,449 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 1,014,577 | $28,874,861 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 653,000 | $28,496,920 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 1,000,000 | $27,590,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,067,320 | $27,102,565 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 2,749,712 | $26,644,709 | dollars as filed | |
| IMMUNOCORE HLDGS PLC | 45258DAB1 | NOTE 2.500% 2/0 | 30,000,000 | $25,849,740 | dollars as filed | principal |
| LIVANOVA PLC | 53802LAB8 | NOTE 2.500% 3/1 | 25,000,000 | $25,399,225 | dollars as filed | principal |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 3,723,131 | $24,200,352 | dollars as filed | |
| VENTAS INC COM | 92276F100 | REIT | 354,000 | $22,355,100 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,616,778 | $20,145,054 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,640,215 | $18,956,744 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 6,710,429 | $18,185,263 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 140,000 | $18,167,800 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 7,964,000 | $18,157,920 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422EAB9 | NOTE 8.000% 7/1 | 10,500,000 | $17,732,075 | dollars as filed | principal |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 1,168,415 | $17,012,122 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 542,020 | $16,965,226 | dollars as filed | |
| VERACYTE INC COM | 92337F107 | Stock | 625,000 | $16,893,750 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 970,590 | $16,839,737 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 2,148,000 | $15,701,880 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 3,255,514 | $15,300,916 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 1,562,942 | $15,144,908 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 825,119 | $14,687,118 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 5,386,000 | $12,441,660 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 888,950 | $11,556,350 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 812,561 | $11,050,830 | dollars as filed | |
| OMADA HEALTH INC | 68170A108 | COM | 553,107 | $10,121,858 | dollars as filed | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 794,865 | $9,752,994 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 613,665 | $9,186,565 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 4,941,565 | $7,758,257 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 373,407 | $7,744,461 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 225,000 | $7,314,750 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,360,052 | $6,888,107 | dollars as filed | |
| SIMULATIONS PLUS INC | 829214105 | COM | 354,089 | $6,178,853 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 500,000 | $5,570,000 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 531,163 | $5,306,318 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 1,890,000 | $4,895,100 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 342,558 | $4,795,812 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,882,654 | $3,746,481 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 1,300,000 | $2,080,000 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $1,477,269 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $1,401,391 | dollars as filed | |
| BIOMX INC | 09090D301 | COM | 2,494,108 | $1,122,349 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 23,827 | $876,595 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 92,787 | $742,296 | dollars as filed | |
| SOTERA HEALTH CO | 83601L102 | COM | 45,242 | $503,091 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 6,328 | $450,300 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 916 | $371,401 | dollars as filed | |
| UFP TECHNOLOGIES INC | 902673102 | COM | 1,517 | $370,391 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 1,945 | $368,247 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 11,138 | $364,992 | dollars as filed | |
| LEMAITRE VASCULAR INC | 525558201 | COM | 4,169 | $346,235 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 15,486 | $332,639 | dollars as filed | |
| ENOVIS CORPORATION | 194014502 | COM | 10,267 | $321,973 | dollars as filed | |
| NATIONAL HEALTHCARE CORP COM | 635906100 | Stock | 2,926 | $313,111 | dollars as filed | |
| DAVITA INC COM | 23918K108 | Stock | 2,101 | $299,287 | dollars as filed | |
| BIOLIFE SOLUTIONS INC COM NEW | 09062W204 | Stock | 13,670 | $294,452 | dollars as filed | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 1,597 | $289,297 | dollars as filed | |
| AMEDISYS INC | 023436108 | COM | 2,744 | $269,982 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 3,529 | $263,299 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 1,623 | $255,769 | dollars as filed | |
| MIMEDX GROUP INC | 602496101 | COM | 39,351 | $240,435 | dollars as filed | |
| MEDPACE HLDGS INC COM | 58506Q109 | Stock | 736 | $231,001 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 917 | $224,188 | dollars as filed | |
| AMPHASTAR PHARMACEUTICALS IN | 03209R103 | COM | 9,579 | $219,934 | dollars as filed | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $217,000 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 1,805 | $213,640 | dollars as filed | |
| CORVEL CORP COM | 221006109 | Stock | 1,993 | $204,841 | dollars as filed | |
| ZOETIS INC CL A | 98978V103 | Stock | 1,310 | $204,295 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 1,628 | $202,491 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 17,083 | $189,621 | dollars as filed | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 55,703 | $189,390 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 16,388 | $158,636 | dollars as filed | |
| PACS GROUP INC | 69380Q107 | COM SHS | 11,421 | $147,559 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 11,301 | $130,866 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 22,574 | $105,421 | dollars as filed | |
| RADNET INC | 750491102 | COM | 1,506 | $85,706 | dollars as filed | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $64,125 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $44,983 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $44,220 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 168 | $33,187 | dollars as filed | |
| EMERGENT BIOSOLUTIONS INC | 29089Q105 | COM | 1,872 | $11,943 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 8,790 | $9,317 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 43 | $6,524 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 166,666 | $3,017 | dollars as filed | |
| MYRIAD GENETICS INC | 62855J104 | COM | 505 | $2,682 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-25-076586 | this filing | 2025-08-14 | acceptance time not in the bulk data set |